Heat-mediated enrichment of α-synuclein from cells and tissue for assessing post-translational modifications

Journal of Neurochemistry

Volumn 126, Issue 5, 2013, Pages 673-684

  Vicente Miranda, Hugo ^a   Xiang, Wei ^b   De Oliveira, Rita M ^a   Simões, Tânia ^c   Pimentel, José ^a,d   Klucken, Jochen ^e   Penque, Deborah ^c   Outeiro, Tiago F ^a,f,g  

^a INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c NATIONAL INSTITUTE OF HEALTH DR RICARDO JORGE   (Portugal)

^d HOSPITAL DE SANTA MARIA   (Portugal)

^e UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^f INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^g UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

Parkinson's disease; post translational modifications; proteomics; synuclein

Indexed keywords

ALPHA SYNUCLEIN; BETA SYNUCLEIN;

ACETYLATION; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; FEMALE; IMMUNOREACTIVITY; NITRATION; NONHUMAN; OLIGOMERIZATION; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN PURIFICATION; PROTEIN STABILITY; PROTEOMICS; RAT; THERMOSTABILITY;

MUS MUSCULUS;

EID: 84883177285     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.12251     Document Type: Article

References (48)

1. Abramoff M. D., Magelhaes P. J., and, Ram S. J., (2004) Image Processing with ImageJ. Biophotonics Int. 11, 36-42.
2. Ahn M., Kim S., Kang M., Ryu Y., and, Kim T. D., (2006) Chaperone-like activities of alpha-synuclein: alpha-synuclein assists enzyme activities of esterases. Biochem. Biophys. Res. Commun. 346, 1142-1149.
3. Altschul S. F., Madden T. L., Schaffer A. A., Zhang J., Zhang Z., Miller W., and, Lipman D. J., (1997) Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 25, 3389-3402.
4. Altschul S. F., Wootton J. C., Gertz E. M., Agarwala R., Morgulis A., Schaffer A. A., and, Yu Y. K., (2005) Protein database searches using compositionally adjusted substitution matrices. FEBS J. 272, 5101-5109.
5. Anderson J. P., Walker D. E., Goldstein J. M., et al,. (2006) Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease. J. Biol. Chem. 281, 29739-29752.
6. Ausubel F. M., Brent R., Kingston R. E., Moore D. D., Seidman J. G., Smith J. A., and, Struhl K., (1990) Current Protocols in Molecular Biology. John Wiley Sons Inc, New York.
7. Bartels T., Choi J. G., and, Selkoe D. J., (2011) alpha-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation. Nature 477, 107-110.
8. Bensalem N., Masscheleyn S., Mozo J., et al,. (2007) High sensitivity identification of membrane proteins by MALDI TOF-MASS spectrometry using polystyrene beads. J. Proteome Res. 6, 1595-1602.
9. Beyer K., (2006) Alpha-synuclein structure, posttranslational modification and alternative splicing as aggregation enhancers. Acta Neuropathol. 112, 237-251.
10. Braak H., Del Tredici K., Rub U., de Vos R. A., Jansen Steur E. N., and, Braak E., (2003) Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol. Aging 24, 197-211.
11. Broersen K., van den Brink D., Fraser G., Goedert M., and, Davletov B., (2006) Alpha-synuclein adopts an alpha-helical conformation in the presence of polyunsaturated fatty acids to hinder micelle formation. Biochemistry 45, 15610-15616.
12. Castellani R., Smith M. A., Richey P. L., and, Perry G., (1996) Glycoxidation and oxidative stress in Parkinson disease and diffuse Lewy body disease. Brain Res. 737, 195-200.
13. ε-(carboxymethyl)lysine linkage to α-synuclein and involvement of advanced glycation end products in α-synuclein deposits in an MPTP-intoxicated mouse model. Biochimie 92, 1379-1386.
14. Cuatrecasas P., Fuchs S., and, Anfinsen C. B., (1968) The tyrosyl residues at the active site of staphylococcal nuclease. Modifications by tetranitromethane. J. Biol. Chem. 243, 4787-4798.
15. Fauvet B., Mbefo M. K., Fares M. B., et al,. (2012) Alpha-synuclein in the central nervous system and from erythrocytes, mammalian cells and E. coli exists predominantly as a disordered monomer. J. Biol. Chem. 287, 15345-15364.
16. Freichel C., Neumann M., Ballard T., et al,. (2007) Age-dependent cognitive decline and amygdala pathology in alpha-synuclein transgenic mice. Neurobiol. Aging 28, 1421-1435.
17. Fujiwara H., Hasegawa M., Dohmae N., Kawashima A., Masliah E., Goldberg M. S., Shen J., Takio K., and, Iwatsubo T., (2002) alpha-Synuclein is phosphorylated in synucleinopathy lesions. Nat. Cell Biol. 4, 160-164.
18. Gai W. P., Yuan H. X., Li X. Q., Power J. T., Blumbergs P. C., and, Jensen P. H., (2000) In situ and in vitro study of colocalization and segregation of alpha-synuclein, ubiquitin, and lipids in Lewy bodies. Exp. Neurol. 166, 324-333.
19. Ghiso J., Wisniewski T., and, Frangione B., (1994) Unifying features of systemic and cerebral amyloidosis. Mol. Neurobiol. 8, 49-64.
20. Giasson B. I., Duda J. E., Murray I. V., Chen Q., Souza J. M., Hurtig H. I., Ischiropoulos H., Trojanowski J. Q., and, Lee V. M., (2000) Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions. Science 290, 985-989.
21. Gomes R. A., Sousa Silva M., Vicente Miranda H., Ferreira A. E., Cordeiro C. A., and, Freire A. P., (2005) Protein glycation in Saccharomyces cerevisiae. Argpyrimidine formation and methylglyoxal catabolism. FEBS J. 272, 4521-4531.
22. Hasegawa M., Fujiwara H., Nonaka T., Wakabayashi K., Takahashi H., Lee V. M., Trojanowski J. Q., Mann D., and, Iwatsubo T., (2002) Phosphorylated alpha-synuclein is ubiquitinated in alpha-synucleinopathy lesions. J. Biol. Chem. 277, 49071-49076.
23. Hirsch E. C., (1993) Does oxidative stress participate in nerve cell death in Parkinson's disease? Eur. Neurol. 33 (Suppl 1), 52-59.
24. Iwatsubo T., (2003) Aggregation of alpha-synuclein in the pathogenesis of Parkinson's disease. J. Neurol. 250 (Suppl 3), III11-III14.
25. Jakes R., Spillantini M. G., and, Goedert M., (1994) Identification of two distinct synucleins from human brain. FEBS Lett. 345, 27-32.
26. Kahle P. J., Neumann M., Ozmen L., et al,. (2000) Subcellular localization of wild-type and Parkinson's disease-associated mutant alpha -synuclein in human and transgenic mouse brain. J. Neurosci. 20, 6365-6373.
27. Kessler J. C., Rochet J. C., and, Lansbury P. T. Jr, (2003) The N-terminal repeat domain of alpha-synuclein inhibits beta-sheet and amyloid fibril formation. Biochemistry 42, 672-678.
28. Kim T. D., Paik S. R., Yang C. H., and, Kim J., (2000) Structural changes in alpha-synuclein affect its chaperone-like activity in vitro. Protein Sci. 9, 2489-2496.
29. Kim T. D., Paik S. R., and, Yang C. H., (2002) Structural and functional implications of C-terminal regions of alpha-synuclein. Biochemistry 41, 13782-13790.
30. Kim T. D., Choi E., Rhim H., Paik S. R., and, Yang C. H., (2004) Alpha-synuclein has structural and functional similarities to small heat shock proteins. Biochem. Biophys. Res. Commun. 324, 1352-1359.
31. Klucken J., Outeiro T. F., Nguyen P., McLean P. J., and, Hyman B. T., (2006) Detection of novel intracellular alpha-synuclein oligomeric species by fluorescence lifetime imaging. FASEB J. 20, 2050-2057.
32. Kruger R., Kuhn W., Muller T., et al,. (1998) Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat. Genet. 18, 106-108.
33. Niedermeyer T. H., and, Strohalm M., (2012) mMass as a software tool for the annotation of cyclic peptide tandem mass spectra. PLoS ONE 7, e44913.
34. Ohrfelt A., Zetterberg H., Andersson K., et al,. (2011) Identification of novel alpha-synuclein isoforms in human brain tissue by using an online nanoLC-ESI-FTICR-MS method. Neurochem. Res. 36, 2029-2042.
35. Oueslati A., Fournier M., and, Lashuel H. A., (2010) Role of post-translational modifications in modulating the structure, function and toxicity of alpha-synuclein: implications for Parkinson's disease pathogenesis and therapies. Prog. Brain Res. 183, 115-145.
36. Paleologou K. E., Schmid A. W., Rospigliosi C. C., et al,. (2008) Phosphorylation at Ser-129 but not the phosphomimics S129E/D inhibits the fibrillation of alpha-synuclein. J. Biol. Chem. 283, 16895-16905.
37. Park S. M., Jung H. Y., Chung K. C., Rhim H., Park J. H., and, Kim J., (2002) Stress-induced aggregation profiles of GST-alpha-synuclein fusion proteins: role of the C-terminal acidic tail of alpha-synuclein in protein thermosolubility and stability. Biochemistry 41, 4137-4146.
38. Polymeropoulos M. H., Lavedan C., Leroy E., et al,. (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276, 2045-2047.
39. Przedborski S., Chen Q., Vila M., et al,. (2001) Oxidative post-translational modifications of alpha-synuclein in the 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease. J. Neurochem. 76, 637-640.
40. Schell H., Hasegawa T., Neumann M., and, Kahle P. J., (2009) Nuclear and neuritic distribution of serine-129 phosphorylated alpha-synuclein in transgenic mice. Neuroscience 160, 796-804.
41. Shevchenko A., Wilm M., Vorm O., and, Mann M., (1996) Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal. Chem. 68, 850-858.
42. Strohalm M., Hassman M., Kosata B., and, Kodicek M., (2008) mMass data miner: an open source alternative for mass spectrometric data analysis. Rapid Commun. Mass Spectrom. 22, 905-908.
43. Strohalm M., Kavan D., Novak P., Volny M., and, Havlicek V., (2010) mMass 3: a cross-platform software environment for precise analysis of mass spectrometric data. Anal. Chem. 82, 4648-4651.
44. Uversky V. N., Yamin G., Munishkina L. A., Karymov M. A., Millett I. S., Doniach S., Lyubchenko Y. L., and, Fink A. L., (2005) Effects of nitration on the structure and aggregation of alpha-synuclein. Brain Res. Mol. Brain Res. 134, 84-102.
45. Wang W., Perovic I., Chittuluru J., et al,. (2011) A soluble alpha-synuclein construct forms a dynamic tetramer. Proc. Natl Acad. Sci. USA 108, 17797-17802.
46. Weinreb P. H., Zhen W., Poon A. W., Conway K. A., and, Lansbury P. T. Jr, (1996) NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded. Biochemistry 35, 13709-13715.
47. Zabrocki P., Bastiaens I., Delay C., Bammens T., Ghillebert R., Pellens K., De Virgilio C., Van Leuven F., and, Winderickx J., (2008) Phosphorylation, lipid raft interaction and traffic of alpha-synuclein in a yeast model for Parkinson. Biochim. Biophys. Acta 1783, 1767-1780.
48. Zarranz J. J., Alegre J., Gomez-Esteban J. C., et al,. (2004) The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann. Neurol. 55, 164-173.